Search Prime Contracts

75A50125C00010

Definitive Contract

Overview

Government Description
CLINICAL DEVELOPMENT OF OX390 (ATIPAMEZOLE) AS AN ?2 AGONIST REVERSAL AGENT FOR HUMAN USE TO COUNTERACT THE SEDATIVE EFFECTS OF XYLAZINE, MEDETOMIDINE, AND OTHER ?2 AGONISTS
Awardee
Place of Performance
Morristown, NJ 7960 United States
Pricing
Cost Sharing
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
46
Orexo Us was awarded Definitive Contract 75A50125C00010 (75A501-25-C-00010) worth up to $50,897,255 by the HHS Office of the Assistant Secretary for Preparedness and Response in September 2025. The contract has a duration of 6 years 5 months and was awarded through solicitation Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) full & open with NAICS 541714 and PSC AN13 via direct negotiation acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $42,446,540.

Status
(Open)

Last Modified 9/24/25
Period of Performance
9/24/25
Start Date
3/31/27
Current End Date
2/4/32
Potential End Date
0% Complete

Obligations and Backlog
$8.5M
Total Obligated
$8.5M
Current Award
$50.9M
Potential Award
17% Funded
$0.0
Funded Backlog
$42.4M
Total Backlog

Award Hierarchy

Definitive Contract

75A50125C00010

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75A50125C00010

Opportunity Lifecycle

Procurement history for 75A50125C00010

People

Suggested agency contacts for 75A50125C00010

Competition

Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
MN1MPMBCVVD5
Awardee CAGE
6Y7L3
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhsjoann_kambaja
Last Modified By
hhsjonathan_gonzalez
Approved By
hhsjonathan_gonzalez

Legislative

Legislative Mandates
None Applicable
Performance District
NJ-11
Senators
Robert Menendez
Cory Booker
Representative
Mikie Sherrill
Modified: 9/24/25